CMTR-CHEMTRAK FDA OK Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CMTR-CHEMTRAK FDA OK

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian H. who wrote (943)	10/17/1997 11:58:00 AM
From: DeadHead	of 1172

Brian, Unfortunately, the one-time payment from AM made up most of CMTR's revenues this last quarter. Without it, they would really be in trouble. Still, I too am confident that they'll find another distribution channel for their HP test. I believe the reason AM backed out of the distribution agreement was because the HP test really does very little to promote Prilosec, which is used to treat ulcer symptoms, and does not rid the patient of the HP bacteria, which we now know is the underlying cause of the ulcer. Like most drug manufacturers, AM has no economic reason to promote a cure for an illness from which they profit treating the symptoms. I was wondering why AM was planning to bundle the CMTR HP test with Prilosec last year when my wife was diagnosed with HP and was prescribed both Prilosec and antibiodics. The antibios were to be taken several times a day and the Prilosec was to be taken only when she experienced pain. My wife never took a single Prilosec and her HP went away using the antibios alone. If her doctor had only prescribed Prilosec, she would probably still be taking it today and for years to come. At $100+ per bottle, that would have been some nice revenue for AM.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next